Wendy Noble

12.0k total citations · 6 hit papers
86 papers, 9.1k citations indexed

About

Wendy Noble is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Wendy Noble has authored 86 papers receiving a total of 9.1k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Physiology, 33 papers in Molecular Biology and 31 papers in Cellular and Molecular Neuroscience. Recurrent topics in Wendy Noble's work include Alzheimer's disease research and treatments (63 papers), Neuroscience and Neuropharmacology Research (27 papers) and Neuroinflammation and Neurodegeneration Mechanisms (17 papers). Wendy Noble is often cited by papers focused on Alzheimer's disease research and treatments (63 papers), Neuroscience and Neuropharmacology Research (27 papers) and Neuroinflammation and Neurodegeneration Mechanisms (17 papers). Wendy Noble collaborates with scholars based in United Kingdom, United States and Italy. Wendy Noble's co-authors include Diane P. Hanger, Brian H. Anderton, Amy M. Pooler, Tong Guo, Christopher C.J. Miller, Dawn H. W. Lau, Claire J. Garwood, Emma Claire Phillips, Patricia Gómez‐Suaga and Sébastien Paillusson and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Wendy Noble

86 papers receiving 8.9k citations

Hit Papers

Long-Term Clinical Efficacy of Grass-Pollen Immunotherapy 1999 2026 2008 2017 1999 2009 2017 2005 2013 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wendy Noble United Kingdom 42 5.6k 3.6k 2.2k 1.6k 1.2k 86 9.1k
Leslie Crews United States 49 3.2k 0.6× 3.1k 0.9× 2.1k 0.9× 1.7k 1.1× 2.4k 1.9× 90 8.8k
Stefan F. Lichtenthaler Germany 55 4.3k 0.8× 4.2k 1.2× 1.3k 0.6× 1.0k 0.6× 617 0.5× 182 9.0k
Lucio Annunziato Italy 58 1.4k 0.2× 5.0k 1.4× 3.5k 1.6× 886 0.6× 818 0.7× 285 10.2k
Philip C. Wong United States 60 7.2k 1.3× 7.2k 2.0× 3.1k 1.4× 2.1k 1.3× 5.3k 4.3× 148 16.6k
G. William Rebeck United States 62 6.8k 1.2× 4.4k 1.2× 2.1k 1.0× 1.8k 1.1× 1.7k 1.4× 138 11.2k
Xia Liu China 51 2.3k 0.4× 4.1k 1.1× 2.1k 0.9× 963 0.6× 836 0.7× 195 8.8k
Mike Hutton United States 40 5.8k 1.0× 3.4k 1.0× 2.1k 0.9× 1.6k 1.0× 2.0k 1.6× 84 9.1k
Jack van Horssen Netherlands 58 1.5k 0.3× 4.2k 1.2× 856 0.4× 3.4k 2.2× 1.2k 1.0× 116 10.2k
Calum Sutherland United Kingdom 45 1.5k 0.3× 5.1k 1.4× 1.2k 0.6× 261 0.2× 205 0.2× 111 8.1k
Hiroshi Mori Japan 54 6.6k 1.2× 4.6k 1.3× 2.0k 0.9× 1.7k 1.1× 3.0k 2.4× 273 12.3k

Countries citing papers authored by Wendy Noble

Since Specialization
Citations

This map shows the geographic impact of Wendy Noble's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy Noble with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy Noble more than expected).

Fields of papers citing papers by Wendy Noble

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendy Noble. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy Noble. The network helps show where Wendy Noble may publish in the future.

Co-authorship network of co-authors of Wendy Noble

This figure shows the co-authorship network connecting the top 25 collaborators of Wendy Noble. A scholar is included among the top collaborators of Wendy Noble based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy Noble. Wendy Noble is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Croft, Cara L., Agnes L. Nishimura, Claire Troakes, et al.. (2024). Reactive astrocytes secrete the chaperone HSPB1 to mediate neuroprotection. Science Advances. 10(12). eadk9884–eadk9884. 13 indexed citations
2.
Matafora, Vittoria, et al.. (2023). Proteomics of the astrocyte secretome reveals changes in their response to soluble oligomeric Aβ. Journal of Neurochemistry. 166(2). 346–366. 8 indexed citations
3.
Martín‐Guerrero, Sandra M., et al.. (2022). Targeting ER-Mitochondria Signaling as a Therapeutic Target for Frontotemporal Dementia and Related Amyotrophic Lateral Sclerosis. Frontiers in Cell and Developmental Biology. 10. 915931–915931. 17 indexed citations
4.
Mórotz, Gábor M., Sandra M. Martín‐Guerrero, Andrea Markovinović, et al.. (2022). The PTPIP51 coiled-coil domain is important in VAPB binding, formation of ER-mitochondria contacts and IP3 receptor delivery of Ca2+ to mitochondria. Frontiers in Cell and Developmental Biology. 10. 920947–920947. 20 indexed citations
5.
Perez‐Nievas, Beatriz Gomez, Martina M. Hughes, Monika A. Myszczynska, et al.. (2021). Astrocytic C–X–C motif chemokine ligand-1 mediates β-amyloid-induced synaptotoxicity. Journal of Neuroinflammation. 18(1). 306–306. 18 indexed citations
6.
Glennon, Elizabeth, Dawn H. W. Lau, Rebecca Gabriele, et al.. (2020). Bridging integrator 1 protein loss in Alzheimer’s disease promotes synaptic tau accumulation and disrupts tau release. Brain Communications. 2(1). 20 indexed citations
7.
Staurenghi, Erica, Paola Gamba, Gabriella Testa, et al.. (2020). Oxysterols present in Alzheimer's disease brain induce synaptotoxicity by activating astrocytes: A major role for lipocalin-2. Redox Biology. 39. 101837–101837. 43 indexed citations
8.
Hanger, Diane P., et al.. (2019). Synaptic Localisation of Tau. Advances in experimental medicine and biology. 1184. 105–112. 20 indexed citations
9.
Mórotz, Gábor M., Elizabeth Glennon, Dawn H. W. Lau, et al.. (2019). Kinesin light chain-1 serine-460 phosphorylation is altered in Alzheimer’s disease and regulates axonal transport and processing of the amyloid precursor protein. Acta Neuropathologica Communications. 7(1). 200–200. 25 indexed citations
10.
Gómez‐Suaga, Patricia, Beatriz Gomez Perez‐Nievas, Elizabeth Glennon, et al.. (2019). The VAPB-PTPIP51 endoplasmic reticulum-mitochondria tethering proteins are present in neuronal synapses and regulate synaptic activity. Acta Neuropathologica Communications. 7(1). 35–35. 124 indexed citations
11.
Croft, Cara L., Ksenia Kurbatskaya, Martina M. Hughes, et al.. (2017). Membrane association and release of wild-type and pathological tau from organotypic brain slice cultures. Cell Death and Disease. 8(3). e2671–e2671. 41 indexed citations
12.
Gómez‐Suaga, Patricia, Sébastien Paillusson, Radu Stoica, et al.. (2017). The ER-Mitochondria Tethering Complex VAPB-PTPIP51 Regulates Autophagy. Current Biology. 27(3). 371–385. 323 indexed citations breakdown →
13.
Bondulich, Marie K., Tong Guo, Christopher Meehan, et al.. (2016). Tauopathy induced by low level expression of a human brain-derived tau fragment in mice is rescued by phenylbutyrate. Brain. 139(8). 2290–2306. 40 indexed citations
14.
Pooler, Amy M., Wendy Noble, & Diane P. Hanger. (2013). A role for tau at the synapse in Alzheimer's disease pathogenesis. Neuropharmacology. 76. 1–8. 154 indexed citations
15.
Noble, Wendy, Diane P. Hanger, Christopher C.J. Miller, & Simon Lovestone. (2013). The Importance of Tau Phosphorylation for Neurodegenerative Diseases. Frontiers in Neurology. 4. 83–83. 321 indexed citations
16.
Noble, Wendy, Diane P. Hanger, & Jean‐Marc Gallo. (2010). Transgenic Mouse Models of Tauopathy in Drug Discovery. CNS & Neurological Disorders - Drug Targets. 9(4). 403–428. 30 indexed citations
17.
Noble, Wendy, Claire J. Garwood, & Diane P. Hanger. (2009). Minocycline as a potential therapeutic agent in neurodegenerative disorders characterized by protein misfolding. Prion. 3(2). 78–83. 56 indexed citations
18.
Cole, Adam R., Wendy Noble, Florian Plattner, et al.. (2007). Collapsin response mediator protein‐2 hyperphosphorylation is an early event in Alzheimer’s disease progression. Journal of Neurochemistry. 103(3). 1132–1144. 150 indexed citations
19.
Derkinderen, Pascal, Timothy M.E. Scales, Diane P. Hanger, et al.. (2005). Tyrosine 394 Is Phosphorylated in Alzheimer's Paired Helical Filament Tau and in Fetal Tau with c-Abl as the Candidate Tyrosine Kinase. Journal of Neuroscience. 25(28). 6584–6593. 153 indexed citations
20.
Noble, Wendy, Vicki Olm, Kazuyuki Takata, et al.. (2003). Cdk5 Is a Key Factor in Tau Aggregation and Tangle Formation In Vivo. Neuron. 38(4). 555–565. 405 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026